4//SEC Filing
Merson Michael R 4
Accession 0001079973-09-000753
CIK 0001167419other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 7:10 PM ET
Size
8.7 KB
Accession
0001079973-09-000753
Insider Transaction Report
Form 4
Merson Michael R
Director
Transactions
- Purchase
Common Stock
2009-08-06$2.85/sh+1,100$3,135→ 5,400 total
Holdings
- 50,000
Stock Options
Exercise: $6.38From: 2008-07-01Exp: 2018-06-30→ Common Stock (50,000 underlying) - 50,000
Stock Options
Exercise: $1.33From: 2009-01-27Exp: 2019-01-27→ Common Stock (50,000 underlying) - 15,674
Stock Options
Exercise: $6.38From: 2008-07-01Exp: 2018-06-30→ Common Stock (15,674 underlying)
Footnotes (1)
- [F1]These options were granted pursuant to the Company's 2002 Stock Incentive Plan. One-third of the options vest each year for three years following the date of grant. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).
Documents
Issuer
AspenBio Pharma, Inc.
CIK 0001167419
Entity typeother
Related Parties
1- filerCIK 0001440213
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 7:10 PM ET
- Size
- 8.7 KB